Browsing WoS İndeksli Yayınlar Koleksiyonu by Author "Ocak, Birol"
Now showing items 1-3 of 3
-
Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study
Bilici, Ahmet; Koca, Sinan; Karaağaç, Mustafa; Eraslan, Emrah; Ocak, Birol; Göktaş Aydın, Sabin; Göksu, Sema Sezgin; Paydaş, Semra; Derin, Sümeyye; Ergün, Yakup; Yekegündüz, Emre; Erol, Cihan; Tataroğlu Özyükseler, Deniz; Demiray, Atike Gökçen; Karaca, Mustafa; Güç, Zeynep Gülsüm; Menekşe, Serkan; Çınkır, Havva Yeşil; Gümüşay, Özge; Sakin, Abdullah (Lippincott Williams and Wilkins, 2022)... -
The predictive importance of body mass index on response to neoadjuvant chemotherapy in patients with breast cancer
Emirzeoğlu, Levent; Arıcı, Serdar; Şahin, Ahmet Bilgehan; Ocak, Birol; Ak, Naziye; Ay, Seval; Mammadov, Elkhan; Turna, Hande; Bilici, Ahmet (Karger, 2023)Purpose: The aim of the study was to investigate the effects of body mass index (BMI) on the response to neoadjuvant chemotherapy (NACT) in Turkish patients with local and locally advanced breast cancer. Methods: The ... -
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: A retrospective Turkish oncology group (TOG) study
Bilici, Ahmet; Koca, Sinan; Karaağaç, Mustafa; Aydın Göktaş, Sabin; Eraslan, Emrah; Kaplan, Muhammed Ali; Ocak, Birol; Göksu, Sema Sezgin; Paydaş, Semra; Akgül, Fahri; Derin, Sümeyye; Ergün, Yakup (Springer, 2023)Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective ...